Extracellular vesicles derived from EZH2-high ovarian cancer cells facilitate omental metastasis by inducing Periostin+ fibroblasts

IF 3.7 2区 生物学 Q2 CELL BIOLOGY Cellular signalling Pub Date : 2025-08-01 Epub Date: 2025-04-01 DOI:10.1016/j.cellsig.2025.111773
Hongmei Liu , Jingni Zhang , Jing Cai , Qiulei Wu , Guoqing Li , Wenhan Li , Tong Liu , Ping Yang , Zehua Wang , Xiaoqing Yi
{"title":"Extracellular vesicles derived from EZH2-high ovarian cancer cells facilitate omental metastasis by inducing Periostin+ fibroblasts","authors":"Hongmei Liu ,&nbsp;Jingni Zhang ,&nbsp;Jing Cai ,&nbsp;Qiulei Wu ,&nbsp;Guoqing Li ,&nbsp;Wenhan Li ,&nbsp;Tong Liu ,&nbsp;Ping Yang ,&nbsp;Zehua Wang ,&nbsp;Xiaoqing Yi","doi":"10.1016/j.cellsig.2025.111773","DOIUrl":null,"url":null,"abstract":"<div><div>The frequent omental metastasis of ovarian cancer (OvCa) at initial diagnosis is due to the omental premetastatic microenvironment, which is rich in activated fibroblasts. However, the molecular events driving the phenotypic transformation of omental fibroblasts that favor metastasis remain largely unexplored. Previously, we found that tumoral enhancer of zest homolog 2 (EZH2), a key epigenetic regulator catalyzing trimethylation at H3K27, played a crucial role in OvCa metastasis. In this study, we revealed that extracellular vesicles (EVs) derived from EZH2-high OvCa cells induce the expression of Periostin (POSTN), but not α-SMA, in omental fibroblasts, facilitating tumor metastasis. Nude mice with intraperitoneal injection of EVs before tumor cell inoculation showed that EVs derived from EZH2-high ovarian cancer cells promote omental metastasis. Human primary omental fibroblasts cocultured with EVs, especially those derived from EZH2-high OvCa cells, exhibited boosted migration, invasion capacities and conditioned medium from EV-activated fibroblasts promotes cancer cell migration, invasion and proliferation. These results may provide novel insight into EZH2-targeted therapy for ovarian carcinoma with intraperitoneal dissemination.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"132 ","pages":"Article 111773"},"PeriodicalIF":3.7000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular signalling","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S089865682500186X","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The frequent omental metastasis of ovarian cancer (OvCa) at initial diagnosis is due to the omental premetastatic microenvironment, which is rich in activated fibroblasts. However, the molecular events driving the phenotypic transformation of omental fibroblasts that favor metastasis remain largely unexplored. Previously, we found that tumoral enhancer of zest homolog 2 (EZH2), a key epigenetic regulator catalyzing trimethylation at H3K27, played a crucial role in OvCa metastasis. In this study, we revealed that extracellular vesicles (EVs) derived from EZH2-high OvCa cells induce the expression of Periostin (POSTN), but not α-SMA, in omental fibroblasts, facilitating tumor metastasis. Nude mice with intraperitoneal injection of EVs before tumor cell inoculation showed that EVs derived from EZH2-high ovarian cancer cells promote omental metastasis. Human primary omental fibroblasts cocultured with EVs, especially those derived from EZH2-high OvCa cells, exhibited boosted migration, invasion capacities and conditioned medium from EV-activated fibroblasts promotes cancer cell migration, invasion and proliferation. These results may provide novel insight into EZH2-targeted therapy for ovarian carcinoma with intraperitoneal dissemination.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
ezh2高表达的卵巢癌细胞外囊泡通过诱导骨膜蛋白+成纤维细胞促进大网膜转移
卵巢癌(OvCa)在最初诊断时的频繁大网膜转移是由于大网膜转移前微环境,其中富含活化的成纤维细胞。然而,驱动大网膜成纤维细胞表型转化并促进转移的分子事件在很大程度上仍未被探索。此前,我们发现zest homolog 2 (EZH2)的肿瘤增强子(tumor enhancer of zest homolog 2, EZH2)是一种催化H3K27位点三甲基化的关键表观遗传调控因子,在OvCa转移中起着至关重要的作用。在本研究中,我们发现来自ezh2 -高OvCa细胞的细胞外囊泡(EVs)诱导大网膜成纤维细胞表达Periostin (POSTN),而不是α-SMA,从而促进肿瘤转移。裸鼠肿瘤细胞接种前腹腔注射EVs,结果显示ezh2高表达卵巢癌细胞衍生的EVs促进大网膜转移。与ev共培养的人原代大网膜成纤维细胞,特别是来自ezh2 -高OvCa细胞的成纤维细胞,表现出增强的迁移和侵袭能力,ev激活成纤维细胞的条件培养基促进癌细胞的迁移、侵袭和增殖。这些结果可能为ezh2腹腔内扩散卵巢癌的靶向治疗提供新的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
文献相关原料
公司名称
产品信息
索莱宝
hematoxylin
来源期刊
Cellular signalling
Cellular signalling 生物-细胞生物学
CiteScore
8.40
自引率
0.00%
发文量
250
审稿时长
27 days
期刊介绍: Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo. Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.
期刊最新文献
A positive SPTBN2-FLI1 feedback axis promotes bladder cancer via PI3K/AKT activation Mild hypothermia alleviates ferroptosis in kidney ischemia-reperfusion injury via the glycolysis-lactate-HMGB1 lactylation axis Mechanistic study on PQQ improving the quality of aged bovine oocytes and early embryonic developmental potential via Nrf2-mediated redox signaling Protein 4.1R regulates CCDC26 and impacts myeloid leukemia progression USP14 and ELAVL1-induced stabilization of VDAC1 aggravates myocardial cell injury in diabetic cardiomyopathy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1